Stay updated with breaking news from Blis Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sweden’s Probi has acquired a cornerstone shareholding in Blis through the cross-licensing deal. NZX-listed Blis Technologies, which sells a suite of health-conscious products and probiotics, today announced a "strategic partnership" with Swedish probiotic manufacturer. The Dunedin-based company issued nearly $9.2 million in new shares Choose your best value subscription option here. Already have an account? Login
Press Release – Make Lemonade New Zealand med-tech companies are using research in biotechnology to help developments in medicine, protective equipment and sensors, BiotechNZ executive director Dr Zahra Champion says. Aucklands Scentian Bio has spent the last decade working out how … New Zealand med-tech companies are using research in biotechnology to help developments in medicine, protective equipment and sensors, BiotechNZ executive director Dr Zahra Champion says. Auckland’s Scentian Bio has spent the last decade working out how to harness insects’ outstanding sense of smell to r...
/cloudfront-ap-southeast-2.images.arcpublishing.com/nzme/R43AQUWA766CWJR7FHJTFLLQU4.jpg)
Market close: Fonterra emerges from trading halt with big dip 7 May, 2021 05:38 AM 4 minutes to read Fonterra Shareholders' Fund fell 30c or 6.52 per cent to $4.30. Photo / File NZ Herald By: Graham Skellern A quiet New Zealand sharemarket caught the end-of-week Fridayitis and closed with a small loss on light trading – and a2 Milk took another dip. The S&P/NZX 50 Index was down 21.74 points or 0.17 per cent to 12,729.92, after trading in a narrow range with an intraday low of 12,699.67. There were 63 gainers and 68 decliners over the whole market of 186 stocks on volume o...
The Dunedin health product company is also making a move into Canada. NZX-listed Blis Technologies, which markets a suite of dental hygiene, vitamin C and throat lozenge products, has downgraded its earnings despite recent expansion into new global markets. The company today said in a market announcement that it was updating its outlook for the current financial year on the basis of recent sales figures and planned investments. Instead of “sustained profit growth” signalled in November last year, and earnings similar to 2020, the company now expects “single-digit growth” and abo...